What we OFFER
Blood-based Genome Signature (BGS)
Blood-based Genome Signature (BGS) is a new personalized assessment healthcare test that uses circulating RNA in the blood to assess an individual's current risk for a panel of diseases.Read More
At DundeeWealth, maintaining and promoting health and wellness is a top priority - the ColonSentry™ test is perfectly aligned with this focus. Early detection of colorectal cancer benefits both our employees and the firm.
Dr. DoullDirector, Human Resources Programs & Administration, DundeeWealth Inc., Toronto, Ontario
I am convinced that this innovative blood test will quickly be adopted as a much-needed screening tool by all of us Family physicians.
Dr. NguyenGTA, Ontario
Patients in general, want to avoid colonoscopy both because of the procedure itself and the bowel preparation necessary. Two years ago a blood test became available to we physicians in Toronto which greatly facilitates the understanding of the potential for cancer of the colon and the advice we give to our patients when screening for colorectal cancer. ColonSentry is now incorporated into the blood draw associated with an annual physical, when appropriate.
Dr. Ron PorterMedical Director, Virtual Wellness Institute
I have been offering ColonSentry as a colorectal cancer option to my patients since 2008. The test is patient friendly in that it consist of a simple blood test. It provides actionable information on the patient's current risk for having the disease and helps facilitate decision making regarding the next steps. It is also useful for colonoscopy-compliant patients as an interval monitoring solution. I had a patient who had low risk ColonSentry score two years earlier and upon a repeat test their risk score had increased significantly into a high risk category. This prompted me to send the patient for colonoscopy, in which polyps were subsequently found and removed.
Dr. Felix Klajner MD, PhD, CCFP,Medical Director, Royal Health Care Centre